Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-10

FDA Approved: AMANTADINE HCL — Supplemental Application (Bionpharma Inc.)

View source ↗

Summary

FDA approves a supplemental application for amantadine hydrochloride submitted by Bionpharma Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • amantadine hydrochloride (amantadine hydrochloride)

Snippet

SUPPL AP for AMANTADINE HCL (AMANTADINE HYDROCHLORIDE)